Asmar L - Search Results

1

Comparison of menopausal symptoms during the first year of adjuvant therapy with either exemestane or tamoxifen in early breast cancer: report of a Tamoxifen Exemestane Adjuvant Multicenter trial substudy.

Jones SE, Cantrell J, Vukelja S, Pippen J, O'Shaughnessy J, Blum JL, Brooks R, Hartung NL, Negron AG, Richards DA, Rivera R, Holmes FA, Chittoor S, Whittaker TL, Bordelon JH, Ketchel SJ, Davis JC, Ilegbodu D, Kochis J, Asmar L. Jones SE, et al. Among authors: asmar l. J Clin Oncol. 2007 Oct 20;25(30):4765-71. doi: 10.1200/JCO.2007.10.8274. J Clin Oncol. 2007. PMID: 17947724 Clinical Trial.

2

Combined-modality treatment of inflammatory breast carcinoma: twenty years of experience at M. D. Anderson Cancer Center.

Ueno NT, Buzdar AU, Singletary SE, Ames FC, McNeese MD, Holmes FA, Theriault RL, Strom EA, Wasaff BJ, Asmar L, Frye D, Hortobagyi GN. Ueno NT, et al. Among authors: asmar l. Cancer Chemother Pharmacol. 1997;40(4):321-9. doi: 10.1007/s002800050664. Cancer Chemother Pharmacol. 1997. PMID: 9225950

3

Impact of selection process on response rate and long-term survival of potential high-dose chemotherapy candidates treated with standard-dose doxorubicin-containing chemotherapy in patients with metastatic breast cancer.

Rahman ZU, Frye DK, Buzdar AU, Smith TL, Asmar L, Champlin RE, Hortobagyi GN. Rahman ZU, et al. Among authors: asmar l. J Clin Oncol. 1997 Oct;15(10):3171-7. doi: 10.1200/JCO.1997.15.10.3171. J Clin Oncol. 1997. PMID: 9336352

4

Prospective randomized trial of paclitaxel alone versus 5-fluorouracil/doxorubicin/cyclophosphamide as induction therapy in patients with operable breast cancer.

Buzdar AU, Hortobagyi GN, Asmar L, Theriault RL, Rahman Z, McNeese M, Singletary S, Ames F. Buzdar AU, et al. Among authors: asmar l. Semin Oncol. 1997 Oct;24(5 Suppl 17):S17-31-S17-34. Semin Oncol. 1997. PMID: 9374089 Clinical Trial.

5

Estrogen replacement therapy after localized breast cancer: clinical outcome of 319 women followed prospectively.

Vassilopoulou-Sellin R, Asmar L, Hortobagyi GN, Klein MJ, McNeese M, Singletary SE, Theriault RL. Vassilopoulou-Sellin R, et al. Among authors: asmar l. J Clin Oncol. 1999 May;17(5):1482-7. doi: 10.1200/JCO.1999.17.5.1482. J Clin Oncol. 1999. PMID: 10334534 Clinical Trial.

6

Paclitaxel by 24-hour infusion with doxorubicin by 48-hour infusion as initial therapy for metastatic breast cancer: phase I results.

Holmes FA, Valero V, Walters RS, Theriault RL, Booser DJ, Gibbs H, Fraschini G, Buzdar AU, Willey J, Frye D, Asmar L, Hortobagyi GN. Holmes FA, et al. Among authors: asmar l. Ann Oncol. 1999 Apr;10(4):403-11. doi: 10.1023/a:1008360406322. Ann Oncol. 1999. PMID: 10370782 Free article. Clinical Trial.

7

Prospective evaluation of paclitaxel versus combination chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide as neoadjuvant therapy in patients with operable breast cancer.

Buzdar AU, Singletary SE, Theriault RL, Booser DJ, Valero V, Ibrahim N, Smith TL, Asmar L, Frye D, Manuel N, Kau SW, McNeese M, Strom E, Hunt K, Ames F, Hortobagyi GN. Buzdar AU, et al. Among authors: asmar l. J Clin Oncol. 1999 Nov;17(11):3412-7. doi: 10.1200/JCO.1999.17.11.3412. J Clin Oncol. 1999. PMID: 10550135 Clinical Trial.

8

Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: The University of Texas M.D. Anderson Cancer Center experience.

Brito RA, Valero V, Buzdar AU, Booser DJ, Ames F, Strom E, Ross M, Theriault RL, Frye D, Kau SW, Asmar L, McNeese M, Singletary SE, Hortobagyi GN. Brito RA, et al. Among authors: asmar l. J Clin Oncol. 2001 Feb 1;19(3):628-33. doi: 10.1200/JCO.2001.19.3.628. J Clin Oncol. 2001. PMID: 11157012 Clinical Trial.

9

Doxorubicin-based adjuvant chemotherapy in elderly breast cancer patients: the M.D. Anderson experience, with long-term follow-up.

Ibrahim NK, Buzdar AU, Asmar L, Theriault RL, Hortobagyi GN. Ibrahim NK, et al. Among authors: asmar l. Ann Oncol. 2000 Dec;11(12):1597-601. doi: 10.1023/a:1008315312795. Ann Oncol. 2000. PMID: 11205469 Free article.

10

Fluorouracil, doxorubicin, and cyclophosphamide followed by tamoxifen as adjuvant treatment for patients with stage IV breast cancer with no evidence of disease.

Rivera E, Holmes FA, Buzdar AU, Asmar L, Kau SW, Fraschini G, Walters R, Theriault RL, Hortobagyi GN. Rivera E, et al. Among authors: asmar l. Breast J. 2002 Jan-Feb;8(1):2-9. doi: 10.1046/j.1524-4741.2002.08002.x. Breast J. 2002. PMID: 11856154 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

121 results

Search Page

Filters